Tissue

Prostate cancer tissue array (4x (2x3) array)，including TNM and pathology grade, 6 cases/24 cores, replacing T196a

Prostate cancer tissue array (4x (2x3) array)，including TNM and pathology grade, 6 cases/24 cores, replacing T196a

Prostate cancer test tissue array, including TNM, Gleason score and pathology grade, 12 cases/24 cores, replaced by T195e

Prostate cancer test tissue array, including TNM, Gleason score and pathology grade, 12 cases/24 cores, replaced by T195e

Prostate cancer test tissue array, including TNM and Gleason grade, 12 cases/24 cores, replacing T195d

Prostate cancer test tissue array, including TNM and Gleason grade, 12 cases/24 cores, replacing T195d

Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases/80 cores, replacing BC19019

Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases/80 cores, replacing BC19019

Prostate cancer and hyperplasia tissue array, including TNM, clinical stage and pathology grade, 32 cases/ 63 cores, replacing BC19017

Prostate cancer and hyperplasia tissue array, including TNM, clinical stage and pathology grade, 32 cases/ 63 cores, replacing BC19017

Prostate cancer and hyperplasia tissue array, including TNM and Gleason grade, 75 cases/75 cores, replacing PR753

Prostate cancer and hyperplasia tissue array, including TNM and Gleason grade, 75 cases/75 cores, replacing PR753

Prostate adenocarcinoma, 100 cases.

Prostate adenocarcinoma, 100 cases.

Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases/80 cores

Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases/80 cores

Progression of liver carcinoma, 40 cases, 1 core/case.

Progression of liver carcinoma, 40 cases, 1 core/case.

Progression of gastric carcinoma: normal gastric mucosa tissue, distal gastric mucosa tissue, adjacent gastric mucosa tissue, primary focus of gastric

Progression of gastric carcinoma: normal gastric mucosa tissue, distal gastric mucosa tissue, adjacent gastric mucosa tissue, primary focus of gastric

Progression of gastric carcinoma tissue array: normal gastric mucosa tissue, distal gastric mucosa tissue, adjacent gastric mucosa tissue, primary focus of gastric cancer, hepatic metastases of gastric cancer, negative lymph node, positive lymph node

Progression of gastric carcinoma tissue array: normal gastric mucosa tissue, distal gastric mucosa tissue, adjacent gastric mucosa tissue, primary focus of gastric cancer, hepatic metastases of gastric cancer, negative lymph node, positive lymph node.

PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 cores

PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 cores

Poorly differentiated breast cancer tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores

Poorly differentiated breast cancer tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores

Pleomorphic liposarcoma tissue array, 30 cases/30 cores

Pleomorphic liposarcoma tissue array, 30 cases/30 cores

Peripheral nerve tumor tissue array, including TNM and clinical stage, 50 cases/100 cores, replacing SO1001

Peripheral nerve tumor tissue array, including TNM and clinical stage, 50 cases/100 cores, replacing SO1001

Penis disease spectrum tissue array, including TNM, clinical stage and pathology grade, 208 cases/ 208 cores

Penis disease spectrum tissue array, including TNM, clinical stage and pathology grade, 208 cases/ 208 cores

Penis disease spectrum (penis tumor progression) tissue array, 59 cases/60 cores

Penis disease spectrum (penis tumor progression) tissue array, 59 cases/60 cores

Penis cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores

Penis cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores

Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Penile (penis) carcinoma tissue array, 80 cases/80 cores

Penile (penis) carcinoma tissue array, 80 cases/80 cores

Pediatric nephroblastoma tissue array, 24 cases/ 48 cores

Pediatric nephroblastoma tissue array, 24 cases/ 48 cores

Pediatric malignant tumor tissue array with normal tissue as control, 70 cases/ 70 cores

Pediatric malignant tumor tissue array with normal tissue as control, 70 cases/ 70 cores

PD-L1 tested non-small cell lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1(Sp263) information, 40 cases/40 core

PD-L1 tested non-small cell lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1(Sp263) information, 40 cases/40 core

Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases/80 cores

Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases/80 cores

Parasite infection tissue array, 12cases/ 24cores

Parasite infection tissue array, 12cases/ 24cores

Parasite infection tissue array with matched tumor as control, including TNM, clinical stage and pathology grade, 20cases/ 80cores

Parasite infection tissue array with matched tumor as control, including TNM, clinical stage and pathology grade, 20cases/ 80cores

Papillary renal cell cancer tissue array, including Fuhrman nuclear classification, TNM and clinical stage, 40 cases/80 cores

Papillary renal cell cancer tissue array, including Fuhrman nuclear classification, TNM and clinical stage, 40 cases/80 cores

Pancreatitis tissue array, 48 cases/48 cores

Pancreatitis tissue array, 48 cases/48 cores

Pancreatitis and matched pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 43 cases/48 cores

Pancreatitis and matched pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 43 cases/48 cores

Pancreatic tumor tissue array, including TNM and clinical stage, 80 cases/ 80 cores

Pancreatic tumor tissue array, including TNM and clinical stage, 80 cases/ 80 cores

Pancreatic ductal adenocarcinoma tissue array, tumor and matched normal adjacent tissue

Pancreatic ductal adenocarcinoma tissue array, tumor and matched normal adjacent tissue

Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info, 40 cases/80 cores

Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info, 40 cases/80 cores

Pancreatic carcinoma, tumor and matched NAT.

Pancreatic carcinoma, tumor and matched NAT.

Pancreatic carcinoma, 63 cases.

Pancreatic carcinoma, 63 cases.

Pancreatic carcinoma and multi-organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases/121 cores

Pancreatic carcinoma and multi-organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases/121 cores

Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/ 80 cores

Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/ 80 cores

Pancreatic cancer tissue array, with adjacent normal pancreas tissue and normal tissue as control, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replaced by PA1001b

Pancreatic cancer tissue array, with adjacent normal pancreas tissue and normal tissue as control, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replaced by PA1001b

Pancreatic cancer tissue array, with adjacent normal pancreas tissue and normal pancreas tissue, including TNM and pathology grade, 50 cases/100 cores, replacing PA1001a

Pancreatic cancer tissue array, with adjacent normal pancreas tissue and normal pancreas tissue, including TNM and pathology grade, 50 cases/100 cores, replacing PA1001a

Pancreatic cancer tissue array with normal pancreatic tissue, including TNM and pathology grade, 24 cases/96 cores, replacing PA721

Pancreatic cancer tissue array with normal pancreatic tissue, including TNM and pathology grade, 24 cases/96 cores, replacing PA721

Pancreatic cancer and normal tissue array, with TNM and pathology grade, 24 cases/72 cores

Pancreatic cancer and normal tissue array, with TNM and pathology grade, 24 cases/72 cores

Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT.

Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT.

Pancreatic adenocarcinoma 31 cases.

Pancreatic adenocarcinoma 31 cases.

Pancreatic adenocarcinoma (30 cases) with matched adjacent normal tissue

Pancreatic adenocarcinoma (30 cases) with matched adjacent normal tissue

Pancreas tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T142a

Pancreas tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T142a

Pancreas tumor tissue array with normal pancreas tissue, including TNM, 6 cases/24 cores, replacing T143

Pancreas tumor tissue array with normal pancreas tissue, including TNM, 6 cases/24 cores, replacing T143

Pancreas tissue array with pancreas cancer tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores

Pancreas tissue array with pancreas cancer tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores

Pancreas tissue array with pancreas cancer tissue, including TNM, clinical stage and pathology grade, 24 cases/24 cores, replacing PAN241

Pancreas tissue array with pancreas cancer tissue, including TNM, clinical stage and pathology grade, 24 cases/24 cores, replacing PAN241

Pancreas intraepithelial neoplasia, pancreatitis and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores

Pancreas intraepithelial neoplasia, pancreatitis and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores

Pancreas disease spectrum (pancreatic cancer progression) with pancreas tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores, replacing PA2081b

Pancreas disease spectrum (pancreatic cancer progression) with pancreas tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores, replacing PA2081b

Pancreas cancer with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing PA483d

Pancreas cancer with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing PA483d

Pancreas cancer with normal tissue array, 24 cases/48 cores, including pathology grade, TNM and clinical stage, 24 cases/48 cores

Pancreas cancer with normal tissue array, 24 cases/48 cores, including pathology grade, TNM and clinical stage, 24 cases/48 cores